News Focus
News Focus
Post# of 257430
Next 10
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

Re: DewDiligence post# 126133

Sunday, 09/04/2011 12:05:34 PM

Sunday, September 04, 2011 12:05:34 PM

Post# of 257430

GILD’s investors are much more concerned about the prospects for Complera and Elvitegravir/Quad.





That's true but John Martin is on record as saying HCV development will be the key growth market going forward.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today